Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: Pep 2-8

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $109 | - | In Stock | |
| 5 mg | $247 | - | In Stock | |
| 10 mg | $400 | - | In Stock | |
| 25 mg | $668 | - | In Stock | |
| 50 mg | $939 | - | In Stock |
| Description | Pep2-8 specifically inhibits PCSK9 activity with a KD of 0.7 μM and an IC50 of 1.4 μM. |
| Targets & IC50 | PCSK9:0.7 μM (Kd), PCSK9:1.4 μM |
| In vitro | Methods: Molecular binding experiments were conducted to verify the binding effect between Pep2-8 and C-terminally truncated PCSK9. A lipid metabolism damage model was established by treating HepG2 cells with PCSK9, and after treatment with 50 μM Pep2-8, the changes in the low-density lipoprotein (LDL) uptake capacity of the cells were detected. Results: Pep2-8 could specifically bind to the C-terminally truncated PCSK9. At a working concentration of 50 μM, Pep2-8 effectively reversed the abnormal cell function induced by PCSK9, restoring the LDL uptake capacity of HepG2 cells to approximately 90% of that in the control group [1]. |
| In vivo | Methods: The binding ability between peptide Pep2-8 and C-terminally truncated PCSK9 was explored. HepG2 cells were treated with PCSK9 to induce functional damage, then treated with 50 μM Pep2-8, and the recovery of LDL uptake function of the cells was detected. Results: Pep2-8 could specifically bind to the C-terminally truncated PCSK9 in a targeted manner. After intervention with 50 μM Pep2-8, the LDL uptake capacity of HepG2 cells damaged by PCSK9 was significantly recovered, reaching approximately 90% of the activity of the normal control group [1]. |
| Synonyms | Pep 2-8 |
| Molecular Weight | 1715.85 |
| Formula | C83H110N16O24 |
| Cas No. | 1541011-97-5 |
| Smiles | [H][C@](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)C(C)C)([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(N)=O |
| Relative Density. | 1.357 g/cm3 (Predicted) |
| Sequence | Ac-Thr-Val-Phe-Thr-Ser-Trp-Glu-Glu-Tyr-Leu-Asp-Trp-Val-NH₂ |
| Sequence Short | TVFTSWEEYLDWV |
| Storage | Keep away from moistureKeep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | PBS (pH 7.4): 2 mg/mL (1.17 mM), Sonication is recommended. DMSO: 80 mg/mL (46.62 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
PBS (pH 7.4)/DMSO
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.